Actively Recruiting
Prevalence of H. Pylori in Stomach Cancers in the West Indies
Led by Centre Hospitalier Universitaire de la Guadeloupe · Updated on 2025-11-18
100
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying stomach cancer in the French West Indies, where rates of this cancer and related deaths are higher than in mainland France. This research aims to find out how common Helicobacter pylori infection is in patients newly diagnosed with stomach cancer. Understanding this prevalence may help improve knowledge about risk factors and prevention, especially since lifestyle and environmental factors might contribute to the high rates. The study observes patients diagnosed with stomach cancer who live in Guadeloupe. It involves detecting H. pylori bacteria in stomach tissue using immunohistochemistry and checking for antibodies against H. pylori through blood tests. This research does not involve treatment but focuses on gathering information to better understand the infection's role in these cancers. Participants will provide consent and undergo tests to detect H. pylori at the time of cancer diagnosis. Researchers will collect data through questionnaires and medical evaluations. The main measurement is the presence of H. pylori detected in tissue samples at baseline, with additional antibody testing. The study runs from early 2025 through 2027, and participants' privacy and safety are respected throughout.
CONDITIONS
Brief Title
Prevalence of H. Pylori in Stomach Cancers in the West Indies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient over 18 years of age residing in Guadeloupe for more than 6 months and with a primary diagnosis of gastric cancer
- Patient having read the information note and having signed the consent to participate in the study
- Patient with social security coverage
You will not qualify if you...
- Refusal to participate
- Patient who could not answer the questionnaires
- Patient not affiliated to a social security scheme
- Patient under legal protection (judicial safeguard, guardianship, curatorship, etc.)
- Pregnant or breastfeeding woman
- Subject participating in another research study that includes an exclusion period still ongoing at the time of pre-inclusion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline
Participants undergo tests to detect H. Pylori infection and assess stomach cancer.
1 visit (in-person)
Duration - Up to study completion in February 2027
Participants' data are observed to improve epidemiological knowledge of stomach cancer and H. Pylori prevalence.
Follow-up visits as needed
Trial Site Locations
Total: 2 locations
1
Cabinet Galeries de Houelbourg
Baie-Mahault, Guadeloupe, 97122
Actively Recruiting
2
CHU de la Guadeloupe
Pointe-à-Pitre, Guadeloupe, 97159
Actively Recruiting
Research Team
M
Mélanie petapermal, Master degree
V
Valérie Hamony Soter
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here